Recursion Pharmaceuticals Inc

Predicción y previsión de precio de Recursion Pharmaceuticals Inc (RXRX)

$3.660

+0.051 (+1.39%)Al cierre

Predicciones de precio

1-Day Price Prediction
-0.43%
1-Week Prediction
-1.79%
1-Month Prediction
—
2026 Prediction
—
2030 Prediction
—

Ábrelo en la app para desbloquear previsiones a más largo plazo.

Loading chart…

Predicción y previsión de RXRX por análisis de gráficos similares

Alphio's RXRX stock price prediction model matches the current Recursion Pharmaceuticals Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $3.62 (-0.43%). The 1-week path is $3.57 (-1.79%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

¿Debería comprar acciones de Recursion Pharmaceuticals Inc?

Recursion Pharmaceuticals Inc (RXRX) is a good buy right now, especially considering the recent surge in milestone payments from its collaboration with Sanofi, which could exceed $300 million. The current price of $3.465 is significantly below the analyst price target of $5.50, indicating a potential upside of 58.6%. Additionally, the RSI is at 35.676, suggesting that the stock is oversold and may be due for a rebound. However, the main risk is the recent 20.53% decline over the last five days, indicating volatility.

RXRX cerró en $3.66 el Tuesday, tras subir +1.39%

Recursion Pharmaceuticals Inc (RXRX) last closed at $3.64, losing -0.55%. These facts feed the 1-day and 1-week RXRX price prediction above.

Factores de la previsión

Los factores de la previsión de Recursion Pharmaceuticals Inc (RXRX) combinan patrones gráficos similares, estacionalidad y medias móviles.

Similar patterns

Positive

Bullish

Seasonality

Negative

Bearish

SMA 20

Negative

Bearish

SMA 200

Positive

Bullish

Patrones gráficos similares

Acciones cuya trayectoria reciente más se parece a la de RXRX, ordenadas por similitud.

Análisis de estacionalidad de RXRX

Historically the probability of a positive October return for RXRX is 6.56%. January offers the highest probability of a positive month at 70.49%, while April is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.

Loading chart…

Proyecciones de precio a 10 años de RXRX

MesPrecio mínimoPrecio medioPrecio máximoROI potencial
Oct 2026$4.81$6.43$7.75+76.75%
Nov 2026$3.30$4.90$6.52+34.69%
Dec 2026$5.32$5.57$6.14+53.04%

En 2026, se proyecta que Recursion Pharmaceuticals Inc (RXRX) oscile entre $3.30 y $7.75.

Previsión mensual de Recursion Pharmaceuticals Inc para 2026

Previsión de RXRX para Oct de 2026
ROI potencial: 76.75%

En Oct de 2026, se proyecta que Recursion Pharmaceuticals Inc promedie $6.43, con un mínimo de $4.81 y un máximo de $7.75.

Previsión de RXRX para Nov de 2026
ROI potencial: 34.69%

En Nov de 2026, se proyecta que Recursion Pharmaceuticals Inc promedie $4.90, con un mínimo de $3.30 y un máximo de $6.52.

Previsión de RXRX para Dec de 2026
ROI potencial: 53.04%

En Dec de 2026, se proyecta que Recursion Pharmaceuticals Inc promedie $5.57, con un mínimo de $5.32 y un máximo de $6.14.

Esta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.

Empezar a operar